Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 1 5Phase 4 4Phase 2 4

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 4Uterine Cervical Dysplasia 3Uterine Cervical Neoplasms 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1Acquired Immunodeficiency Syndrome 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7human papillomavirus vaccine, L1 type 16, 18 6Papillomavirus Vaccines 4Vaccines 2Engerix-B 2adacel 1Vaccines, Synthetic 1Tetanus Toxoid 1Methods 1Hepatitis A Vaccines 1Educational Status 1Early Intervention, Educational 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Papillomavirus Infections × Papillomavirus Vaccines × Clear all
NCT04235257 2026-05-05

Intradermal, Fractional Dose of HPV Vaccines:

University of Washington

Phase 4 Active not recruiting
40 enrolled

Papillomavirus Infections

NCT05291871 2026-05-05

Immunogenicity of Fractional Dose of the HPV Vaccines

University of Washington

Phase 4 Active not recruiting
92 enrolled

Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01824537 2025-03-19

TRAP-HPV

McGill University

Phase 4 Completed
372 enrolled 12 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡